Publications
A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice
J Invest Dermatol. - October 2024
Validation of alopecia coding in US claims data among women of childbearing age
Pharmacoepidemiol Drug Saf. - April 2024
Semiparametric allocation of subjects to cohort strata
Epidemiology - March 2024
Prevalence of pretreatment testing recommended for patients with chronic inflammatory skin diseases
JAMA Dermatol - January 2024
Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: a US nation-wide cohort study
J Am Acad Dermatol - August 2023
Venous thromboembolism in patients with bullous pemphigoid
JAMA Dermatol - July 2023
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis
Pharmacoepidemiology Drug Saf - March 2023
Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study
J Am Acad Dermatol - March 2023
Risk of infection in children with psoriasis receiving treatment with Ustekinumab, Etanercept, or Methotrexate before and after labeling expansion
JAMA Dermatol - March 2023
Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis
Pediatr Dermatol - January 2023
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease
Gut - September 2022
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study
Br J Dermatol - June 2022
Venous thromboembolism in chronic inflammatory skin diseases-the need to consider bullous pemphigoid-reply
JAMA Dermatol - March 2022
Incidence of bacterial and nonbacterial conjunctivitis in patients with atopic dermatitis treated with dupilumab: A US multidatabase cohort study
Dermatitis - February 2022
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy
Pharmacoepidemiol Drug Saf - February 2022
Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis
J Am Acad Dermatol - August 2021
Incidence of venous thromboembolism in patients with dermatologist-diagnosed chronic inflammatory skin diseases
JAMA Dermatol - July 2021
Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study
J Am Acad Dermatol - February 2021
Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study
J Am Acad Dermatol - June 2020
Risk of inflammatory arthritis after a new diagnosis of hidradenitis suppurativa
JAMA Dermatol - March 2020
Rationale and design of the Brigham cohort for psoriasis and psoriatic arthritis registry (COPPAR)
JBMC Dermatol - August 2017